Investigation Overview
An investigation on behalf of investors, who currently hold shares of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), was announced concerning whether the takeover of Sucampo Pharmaceuticals, Inc. by Mallinckrodt plc for $18.00 per share is unfair to NASDAQ:SCMP stockholders. The investigation by a law firm concerns whether certain officers and directors of Sucampo Pharmaceuticals, Inc....
You must register (for free) or login to view the entire investigation.